Low-dose propofol for the abortive treatment of pediatric migraine in the emergency department

Pediatric Emergency Care

Volumn 28, Issue 12, 2012, Pages 1293-1296

  Sheridan, David C ^a   Spiro, David M ^a,b   Nguyen, Thuan ^c   Koch, Thomas K ^c,d   Meckler, Garth D ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Department of Emergency Medicine   (United States)

^c Department of Public Health and Preventative Medicine ^*  (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

abortive; headache; migraine; propofol

Indexed keywords

DIPHENHYDRAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; PROPOFOL;

ADOLESCENT; APNEA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEADACHE; HUMAN; HYPOTENSION; HYPOVENTILATION; HYPOXIA; LENGTH OF STAY; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MIGRAINE; OUTCOME ASSESSMENT; PEDIATRICS; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; VISUAL ANALOG SCALE;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHILD; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MIGRAINE DISORDERS; PAIN MEASUREMENT; PROCHLORPERAZINE; PROPOFOL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871625132     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3182768a6b     Document Type: Article

References (10)

1. Lewis DW. Pediatric migraine. Pediatr Rev. 2007;28:43-53. (Pubitemid 46495844)
2. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215-2224.
3. Joseph MM, Webb K. Evidence-based assessment and treatment of acute headache in the children and adolescents in the ED. Pediatr Emerg Med Pract. 2005;2;1-28.
4. Kabbouche MA, Powers SW, Segers A, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49:106-109.
5. Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40:224-230. (Pubitemid 30169887)
6. Drummond-Lewis J, Scher C. Propofol: a new treatment strategy for refractory migraine headache. Pain Med. 2002;3:366-369. (Pubitemid 36040741)
7. Bloomstone JA. Propofol: a novel treatment for breaking migraine headache. Anesthesiology. 2007;106:405-406. (Pubitemid 46185200)
8. Shah A, Mosdossy G, McLeod S, et al. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med. 2011;57:425-433.
9. Mallory MD, Baxter AL, Yanosky DJ, et al. Emergency physician- administered propofol sedation: a report on 25,433 sedations from the pediatric sedation research consortium. Ann Emerg Med. 2011;57:462-468.
10. Skokan EG, Pribble C, Bassett KE, et al. Use of propofol sedation in a pediatric emergency department: a prospective study. Clin Pediatr (Phila). 2001;40:663-671. (Pubitemid 33139168)